Jennifer Lee

About

With a strong track record of expediting breakthrough therapies, Jennifer has contributed to the FDA approvals of seven novel therapies, generating $20 billion in value. An investor and STEM advocate, she focuses her investments on companies advancing science and technology for global impact. Jennifer serves on multiple private and non-profit boards and is a published author in esteemed medical and scientific journals. She holds a bachelor's degree in Biochemistry from the University of Illinois and a master's in Regulatory Compliance from Northwestern University.

Source (opens in a new tab)